JamesMichaelKrellMD

Dermatology • Birmingham, AL

Physician

Join to view full profile

Dr. Krell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Krell's full profile

Already have an account?

Office
2100 16th Ave S
Suite 202
Birmingham, AL 35205
Phone+1 205-933-0987

Fax+1 205-930-1750
Is this information wrong?

Education & Training

Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1989 - 1990
Harvard Medical SchoolClass of 1989

Certifications & Licensure

GA State Medical License 1990 - 2025
AL State Medical License 1993 - 2024
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Top MD Consumers Checkbook

Clinical Trials

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
Completed
Phase 3
This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is Start of enrollment: 2018 Sep 17
Completed
Phase 2
A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is Start of enrollment: 2019 Mar 18
Terminated
Phase 2
A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata Start of enrollment: 2019 Jul 08
Active, not recruiting
Phase 3
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis Start of enrollment: 2019 Aug 12
Active, not recruiting
Phase 3
A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis Start of enrollment: 2020 Jun 04
Completed
Phase 2
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
Recruiting
Phase 3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

30 citations
Secukinumab improves patient-reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo-controlled clinical trials.
Bruce Strober, Bárður Sigurgeirsson, Georg Popp, Rodney Sinclair, James Krell, Sigitas Stonkus, Marcis Septe, Boni E. Elewski, Alice B. Gottlieb, Yang Zhao, Mary H. Tr...> ;International Journal of Dermatology. 2016 Apr 1
1 citations
Immune response to pneumococcal polysaccharide vaccine in adults with chronic plaque psoriasis treated with alefacept
Charles Lynde, James Krell, Neil J. Korman, Barbara Mathes> ;Journal of the American Academy of Dermatology. 2011 Oct 1
16 citations
An open-label study evaluating the efficacy and tolerability of alefacept for the treatment of scalp psoriasis.
James Krell, Candi Nelson, Linda Spencer, Stephen Miller> ;Journal of the American Academy of Dermatology. 2008 Apr 1
17 citations
Epithelial sheath neuroma: a case report and discussion of the literature.
Tai-Yuan David Lin, Alexandra Y. Zhang, Ilene B. Bayer-Garner, James M. Krell, Scott M. Acker> ;The American Journal of Dermatopathology. 2006 Jun 1
13 citations
Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept.
James Krell> ;Journal of the American Academy of Dermatology. 2006 Jun 1
Nodular scleroderma.
Krell, J. M., Solomon, A. R., Glavey, C. M., Lawley, T. J.> ;J Am Acad Dermatol. 1995 Feb
78 citations
Diffuse dermal angiomatosis: a variant of reactive cutaneous angioendotheliomatosis
James M. Krell, Ramon L. Sanchez, Alvin R. Solomon> ;Journal of Cutaneous Pathology. 1994 Aug 1
Join now to see all

Professional Memberships

American Academy of Dermatology - AAD
Fellow

Hospital Affiliations

Cooper Green HospitalBirmingham, Alabama
Grandview Medical CenterBirmingham, Alabama
Tuscaloosa VA Medical CenterTuscaloosa, Alabama
Birmingham VA Medical CenterBirmingham, Alabama

JamesMichaelKrellMD

Dr. Krell is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Professional Memberships

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.